Advanced search

1638 Results

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Novo Nordisk A/S - share repurchase programme	05-27	GL
Statement: Zantac (ranitidine) litigation - Valadez and Williams cases - Form 6-K	05-24	PU
Sirius XM : SiriusXM Announces Coverage for the 108th Running of the Indianapolis 500	05-21	PU
GSK : announces positive results from phase III severe asthma trials of depemokimab - Form 6-K	05-21	PU
Novo Nordisk A/S - share repurchase programme	05-17	GL
GSK : completes sale of remaining shares in Haleon - Form 6-K	05-17	PU
AMC Networks’ June Highlights Features the Premiere of Highly Anticipated New AMC Series Orphan Black: Echoes; Sundance Now’s New Supernatural Drama Domino Day; and Return of Acorn TV’s Hit Crime Series My Life is Murder	05-16	PU
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons	05-15	GL
Horace Mann Educators : Q1 2024 Call Transcript	05-14	PU
Transcript : FreightCar America, Inc. - Shareholder/Analyst Call	05-14
Novo Nordisk A/S: Once-weekly and once-monthly Mim8 demonstrate superior reduction of treated bleeding episodes compared to on-demand and prior prophylaxis treatment in people with haemophilia A in the Frontier 2 trial	05-13	GL
Transcript : James River Group Holdings, Ltd., Q1 2024 Earnings Call, May 09, 2024	05-09
Transcript : Killam Apartment REIT - Shareholder/Analyst Call	05-08
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons	05-08	GL
K+S : Presentation May 2024	05-07	PU
American Financial : Q1 2024 Earnings Release Transcript	05-06	PU
Trading in Novo Nordisk shares by board members, executives and associated persons	05-06	GL
Novo Nordisk A/S - share repurchase programme	05-06	GL
Novo Nordisk A/S purchases B shares worth DKK 5,428 million from Novo Holdings A/S under the 2024 share repurchase programme	05-06	GL
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons	05-03	GL
Transcript : Lincoln Educational Services Corporation - Shareholder/Analyst Call	05-02
Novo Nordisk A/S : Go to the Q1 2024 company announcement	05-02	PU
Novo Nordisk's sales increased by 22% in Danish kroner and by 24% at constant exchange rates to DKK 65.3 billion in the first three months of 2024	05-02	GL
Novo Nordisk A/S - share repurchase programme	05-01	GL
Hartford Financial Services : 1Q24 Webcast Transcript	04-26	PU
CMS: BP p.l.c.: Release of a capital market information	04-25	EQ
Novo Nordisk A/S : Reduction of the share capital	04-24	PU
Novo Nordisk A/S – Reduction of the share capital	04-24	GL
Novo Nordisk A/S - share repurchase programme	04-22	GL
Crimson Tide plc Appoints Philip Douglas James Meyers as Director	04-18	CI
GSK : EAGLE-1 phase III data show potential for gepotidacin as a new oral treatment option for uncomplicated urogenital gonorrhoea (GC) amid growing resistance to existing treatments - Form 6-K	04-17	PU
Crimson Tide plc Announces CEO Changes	04-17	CI
Transcript : Cooper Energy Limited, Q3 2024 Earnings Call, Apr 16, 2024	04-15
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons	04-15	GL
Novo Nordisk A/S - share repurchase programme	04-15	GL
Novo Nordisk A/S - share repurchase programme	04-08	GL
Novo Nordisk A/S - share repurchase programme	04-02	GL
Zions Bancorporation N A : 2023 Annual Report Officers & Directors	03-28	PU
INDUS acquires British company COLSON X-Cel in the future field of measurement and control technology	03-27	EQ
INDUS : acquires British company COLSON X-Cel in the future field of measurement and control technology	03-27	PU
Novo Nordisk A/S - share repurchase programme	03-25	GL
Novo Nordisk to acquire Cardior Pharmaceuticals and strengthen pipeline in cardiovascular disease	03-25	GL
Awiqli® (once-weekly basal insulin icodec) recommended for approval for the treatment of diabetes by the European regulatory authorities	03-21	GL
Resolutions from the Annual General Meeting of Novo Nordisk A/S	03-21	AQ
Resolutions from the Annual General Meeting of Novo Nordisk A/S	03-21	GL
FreightCar America, Inc. Announces CEO Transition	03-18	AQ
FreightCar America, Inc. Announces CEO Changes	03-18	CI
FreightCar America, Inc. Announces Board Changes	03-18	CI
Novo Nordisk A/S - share repurchase programme	03-18	GL
K+S : Presentation March 2024	03-12	PU

No results for this search

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer